Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 2.13%11.11B | -0.32%23.51B | -3.53%10.88B | 2.87%23.59B | 4.08%11.27B | -4.41%22.93B | -4.83%10.83B | 9.03%23.98B | 10.52%11.38B | 9.47%22B |
| Operating income | 2.13%11.11B | -0.32%23.51B | -3.53%10.88B | 2.87%23.59B | 4.08%11.27B | -4.41%22.93B | -4.83%10.83B | 9.03%23.98B | 10.52%11.38B | 9.47%22B |
| Cost of sales | -4.20%-5.98B | 2.17%-12.32B | 7.11%-5.74B | 2.04%-12.6B | 0.33%-6.17B | 2.87%-12.86B | -2.23%-6.19B | -16.19%-13.24B | -13.56%-6.06B | -9.13%-11.39B |
| Operating expenses | -4.20%-5.98B | 2.17%-12.32B | 7.11%-5.74B | 2.04%-12.6B | 0.33%-6.17B | 2.87%-12.86B | -2.23%-6.19B | -16.19%-13.24B | -13.56%-6.06B | -9.13%-11.39B |
| Gross profit | -0.19%5.13B | 1.80%11.19B | 0.80%5.14B | 9.13%10.99B | 9.97%5.1B | -6.29%10.07B | -12.87%4.64B | 1.34%10.75B | 7.25%5.32B | 9.84%10.61B |
| Selling expenses | -13.23%-1.55B | -0.19%-3.03B | 7.19%-1.37B | -0.10%-3.02B | -0.72%-1.47B | 3.67%-3.02B | -2.63%-1.46B | -13.29%-3.13B | -14.15%-1.43B | 0.91%-2.77B |
| Administrative expenses | -8.33%-1.65B | 1.15%-3.01B | -2.84%-1.53B | -6.81%-3.04B | -5.54%-1.48B | -4.19%-2.85B | -3.31%-1.41B | -0.78%-2.73B | -4.31%-1.36B | -9.17%-2.71B |
| Special items of operating profit | 12.82%331.23M | -0.01%683.21M | -11.81%293.58M | 6.26%683.26M | 9.73%332.9M | 11.37%643.01M | 24.17%303.38M | -5.30%577.36M | 95.19%244.32M | 42.66%609.7M |
| Operating profit | -11.02%2.26B | 4.06%5.84B | 2.63%2.54B | 15.74%5.61B | 19.47%2.48B | -11.18%4.85B | -25.48%2.07B | -4.87%5.46B | 9.69%2.78B | 19.36%5.74B |
| Financing income | -62.42%21.4M | 1.79%78.39M | 41.44%56.94M | -52.89%77.01M | -74.60%40.26M | -63.19%163.48M | -15.82%158.49M | -5.34%444.13M | -30.31%188.26M | -16.04%469.16M |
| Financing cost | 47.43%-48.53M | 37.46%-176.23M | 38.18%-92.32M | -26.97%-281.79M | -97.46%-149.33M | -35.05%-221.93M | 11.03%-75.63M | 21.14%-164.33M | 15.11%-85.01M | 33.33%-208.38M |
| Share of profits of associates | ---4.46M | -84.12%67K | ---- | 105.08%422K | 108.90%419K | -272.06%-8.31M | -197.41%-4.71M | -5.43%-2.23M | -50.91%-1.58M | 36.85%-2.12M |
| Earning before tax | -11.03%2.23B | 6.18%5.74B | 5.85%2.51B | 13.09%5.41B | 10.08%2.37B | -16.64%4.78B | -25.40%2.15B | -4.34%5.73B | 6.60%2.88B | 18.74%5.99B |
| Tax | 20.39%-511.89M | 0.78%-1.41B | -0.51%-643.02M | -0.36%-1.42B | -14.20%-639.73M | 8.29%-1.42B | 29.85%-560.17M | 16.34%-1.55B | -5.47%-798.52M | -30.77%-1.85B |
| After-tax profit from continuing operations | -7.79%1.72B | 8.67%4.33B | 7.82%1.86B | 18.45%3.98B | 8.62%1.73B | -19.73%3.36B | -23.69%1.59B | 1.00%4.19B | 7.04%2.08B | 14.07%4.15B |
| Earning after tax | -7.79%1.72B | 8.67%4.33B | 7.82%1.86B | 18.45%3.98B | 8.62%1.73B | -19.73%3.36B | -23.69%1.59B | 1.00%4.19B | 7.04%2.08B | 14.07%4.15B |
| Minority profit | 81.81%-191K | 1.99%-7.15M | 79.24%-1.05M | 17.78%-7.3M | 15.34%-5.06M | 34.47%-8.87M | 4.49%-5.98M | -33.70%-13.54M | -9.68%-6.26M | 21.92%-10.13M |
| Profit attributable to shareholders | -7.83%1.72B | 8.65%4.34B | 7.57%1.86B | 18.36%3.99B | 8.53%1.73B | -19.77%3.37B | -23.64%1.6B | 1.08%4.2B | 7.05%2.09B | 13.94%4.16B |
| Basic earnings per share | -7.79%0.1455 | 9.09%0.3671 | 8.23%0.1578 | 18.69%0.3365 | 8.72%0.1458 | -19.37%0.2835 | -22.58%0.1341 | 3.93%0.3516 | 9.97%0.1732 | 15.15%0.3383 |
| Diluted earnings per share | -7.79%0.1455 | 9.09%0.3671 | 8.23%0.1578 | 18.69%0.3365 | 8.72%0.1458 | -19.37%0.2835 | -22.58%0.1341 | 3.93%0.3516 | 9.97%0.1732 | 15.15%0.3383 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young Accounting Firm | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.